REGN · Regeneron Pharmaceuticals Inc.
AI read · Good for REGN
The AI's read
This gives Regeneron more evidence that Pasatru can keep a severe, disabling condition under control. The placebo comparison showed no new bone lesions and fewer flare-ups. Infections became more common at higher doses, but each case was managed and no patient stopped treatment. A trial in children and teens is planned, but has not begun.